Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55.267
Filtrar
1.
Biomaterials ; 313: 122799, 2025 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-39243671

RESUMO

Gene therapy offers a promising avenue for treating ischemic diseases, yet its clinical efficacy is hindered by the limitations of single gene therapy and the high oxidative stress microenvironment characteristic of such conditions. Lipid-polymer hybrid vectors represent a novel approach to enhance the effectiveness of gene therapy by harnessing the combined advantages of lipids and polymers. In this study, we engineered lipid-polymer hybrid nanocarriers with tailored structural modifications to create a versatile membrane fusion lipid-nuclear targeted polymer nanodelivery system (FLNPs) optimized for gene delivery. Our results demonstrate that FLNPs facilitate efficient cellular uptake and gene transfection via membrane fusion, lysosome avoidance, and nuclear targeting mechanisms. Upon encapsulating Hepatocyte Growth Factor plasmid (pHGF) and Catalase plasmid (pCAT), HGF/CAT-FLNPs were prepared, which significantly enhanced the resistance of C2C12 cells to H2O2-induced injury in vitro. In vivo studies further revealed that HGF/CAT-FLNPs effectively alleviated hindlimb ischemia-induced gangrene, restored motor function, and promoted blood perfusion recovery in mice. Metabolomics analysis indicated that FLNPs didn't induce metabolic disturbances during gene transfection. In conclusion, FLNPs represent a versatile platform for multi-dimensional assisted gene delivery, significantly improving the efficiency of gene delivery and holding promise for effective synergistic treatment of lower limb ischemia using pHGF and pCAT.


Assuntos
Terapia Genética , Isquemia , Lipídeos , Polímeros , Animais , Isquemia/terapia , Terapia Genética/métodos , Lipídeos/química , Camundongos , Polímeros/química , Nanopartículas/química , Fator de Crescimento de Hepatócito/genética , Linhagem Celular , Transfecção/métodos , Plasmídeos/genética , Técnicas de Transferência de Genes , Masculino , Membro Posterior/irrigação sanguínea , Catalase/metabolismo
2.
Biomaterials ; 313: 122768, 2025 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-39232332

RESUMO

As the most prominent and ideal modality in female fertility preservation, ovarian tissue cryopreservation, and transplantation often confront the challenge of ischemic damage and follicular loss from avascular transplantation. To surmount this impediment, we engineered a novel platelet-derived factors-encapsulated fibrin hydrogel (PFH), a paradigmatic biomaterial. PFH encapsulates autologous platelet-derived factors, utilizing the physiological blood coagulation cascade for precise local delivery of bioactive molecules. In our study, PFH markedly bolstered the success of avascular ovarian tissue transplantation. Notably, the quantity and quality of follicles were preserved with improved neovascularization, accompanied by decreased DNA damage, increased ovulation, and superior embryonic development rates under a Low-concentration Platelet-rich plasma-derived factors encapsulated fibrin hydrogel (L-PFH) regimen. At a stabilized point of tissue engraftment, gene expression analysis mirrored normal ovarian tissue profiles, underscoring the effectiveness of L-PFH in mitigating the initial ischemic insult. This autologous blood-derived biomaterial, inspired by nature, capitalizes on the blood coagulation cascade, and combines biodegradability, biocompatibility, safety, and cost-effectiveness. The adjustable properties of this biomaterial, even in injectable form, extend its potential applications into the broader realm of personalized regenerative medicine. PFH emerges as a promising strategy to counter ischemic damage in tissue transplantation, signifying a broader therapeutic prospect. (197 words).


Assuntos
Preservação da Fertilidade , Hidrogéis , Isquemia , Neovascularização Fisiológica , Ovário , Feminino , Animais , Preservação da Fertilidade/métodos , Neovascularização Fisiológica/efeitos dos fármacos , Ovário/efeitos dos fármacos , Hidrogéis/química , Isquemia/terapia , Humanos , Fibrina/química , Plasma Rico em Plaquetas/metabolismo
3.
Vasa ; 53(5): 341-351, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39252599

RESUMO

The management of embolic acute limb ischaemia commonly involves determining aetiology and performing emergency invasive procedures. This detailed study aimed to determine the impact of manipulation of anticoagulation in the aetiology of emboli in acute limb ischaemia and determine the efficacy of primary anticoagulation therapy vs. invasive interventions. Material and methods: Data collection was conducted at a single institution on a cohort of patients presenting consecutively with embolic acute limb ischaemia over one year. Two groups were compared, one receiving anticoagulation as primary therapy with those undergoing invasive treatment as the internal comparison group. Results: A likely haematological causation was identified in 22 of 38 presentations, related to interruption of anticoagulation in cardiac conditions, the majority atrial fibrillation (n=12), or hypercoagulable states (n=10). Limb salvage was pursued in 36 patients employing anticoagulation (n=19) or surgical embolectomy (n=17) as the primary therapy in upper and lower limbs (n=17 vs n=19 respectively). Despite delays often well beyond six hours and a range of ischaemic severity in both groups, 35 of 36 patients achieved full or substantive restoration of function with improved perfusion. Regarding anatomical distribution of arterial disease and therapy, three patients with multi-level disease proceeded to embolectomy following anticoagulation. Embolectomy was undertaken most often for proximal emboli and more profound paralysis. Conclusions: Anticoagulation and coagulopathy are commonly implicated in the aetiology of arterial emboli, with omission of effective anticoagulation in atrial fibrillation being associated in almost 1/3 of presentations. Whilst more profound limb paralysis and proximal or multi-level disease tended to be managed surgically, primary anticoagulation therapy alone or with a secondary embolectomy was effective across the spectrum of ischaemia severity and despite significant delays beyond guideline recommendations.


Assuntos
Anticoagulantes , Embolectomia , Embolia , Isquemia , Salvamento de Membro , Humanos , Anticoagulantes/uso terapêutico , Anticoagulantes/efeitos adversos , Feminino , Masculino , Idoso , Embolectomia/efeitos adversos , Isquemia/tratamento farmacológico , Isquemia/diagnóstico , Resultado do Tratamento , Embolia/etiologia , Embolia/prevenção & controle , Embolia/diagnóstico , Doença Aguda , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Fatores de Tempo , Fatores de Risco , Estudos Retrospectivos , Doença Arterial Periférica/tratamento farmacológico , Doença Arterial Periférica/diagnóstico , Recuperação de Função Fisiológica
4.
EuroIntervention ; 20(18): e1163-e1172, 2024 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-39279518

RESUMO

BACKGROUND: Although femoropopliteal-specific stents have durable patency, stent thrombosis (ST) may occur, which can lead to acute limb ischaemia (ALI). AIMS: We aimed to investigate the clinical features and outcomes of ALI caused by femoropopliteal ST in patients with lower extremity artery disease. METHODS: This multicentre retrospective study included 499 patients with ALI - of whom 108 patients had ALI caused by femoropopliteal ST (ST-ALI) and 391 patients had ALI caused by other aetiologies (de novo ALI) - who underwent treatment between September 2011 and March 2023. Clinical features and outcomes were compared between the two groups. The primary outcome measure was 12-month amputation-free survival; factors associated with amputation or death were investigated using multivariate Cox proportional hazards regression analysis. RESULTS: Patients with ST-ALI were significantly more likely to exhibit conventional atherosclerotic risk factors, including diabetes mellitus (63% vs 26%) and haemodialysis (51% vs 10%) compared to patients with de novo ALI, whereas patients with de novo ALI were older (80 years vs 74 years) and more likely to have atrial fibrillation (49% vs 18%) than patients with ST-ALI. The 12-month amputation-free survival rate was significantly lower in the ST-ALI group than that in the de novo ALI group (51% vs 76%; p<0.001). Multivariate analysis revealed that ST-ALI, older age, haemodialysis, atrial fibrillation, the presence of a wound, peak C-reactive protein level, and non-ambulatory status all have an independent, positive association with death or major amputation. CONCLUSIONS: The current study revealed that patients with ST-ALI had worse clinical outcomes than those with de novo ALI, highlighting the need to maximise ST prevention.


Assuntos
Amputação Cirúrgica , Artéria Femoral , Isquemia , Doença Arterial Periférica , Artéria Poplítea , Stents , Trombose , Humanos , Masculino , Idoso , Feminino , Estudos Retrospectivos , Artéria Poplítea/cirurgia , Isquemia/terapia , Isquemia/mortalidade , Isquemia/etiologia , Isquemia/cirurgia , Artéria Femoral/cirurgia , Doença Arterial Periférica/terapia , Doença Arterial Periférica/complicações , Doença Arterial Periférica/cirurgia , Doença Arterial Periférica/mortalidade , Idoso de 80 Anos ou mais , Pessoa de Meia-Idade , Trombose/etiologia , Trombose/mortalidade , Resultado do Tratamento , Fatores de Risco , Salvamento de Membro , Procedimentos Endovasculares/instrumentação , Procedimentos Endovasculares/efeitos adversos , Extremidade Inferior/irrigação sanguínea , Doença Aguda , Grau de Desobstrução Vascular
6.
Ther Adv Cardiovasc Dis ; 18: 17539447241271989, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39245988

RESUMO

Acute limb ischemia (ALI) due to arterial thromboembolic occlusion is a critical emergency in vascular medicine, requiring attention for rapid diagnosis and intervention, to prevent limb loss and major amputation, which is associated with patient disability in the long term. Traditionally, surgical embolectomy has been used for the treatment of ALI. Endovascular treatment of ALI traditionally involved catheter-directed thrombolysis. This option, however, poses some limitations, including an increased risk for access site and systemic bleeding complications, especially in patients with high bleeding risk. Therefore, in the last decades, several devices have been developed and tested for the mechanical endovascular treatment of ALI. Such devices involve either rotational thrombectomy or continuous thrombus aspiration. While rotational thrombectomy is limited in rather large arteries due to the risk of dissection and perforation in arteries <3 mm, continuous thrombus aspiration can be applied in smaller vessels and tortuous anatomies. In our case series we present a minimal-invasive endovascular approach for the treatment of two patients with ALI due to thrombotic occlusion of tortious and small diameter arteries. Minimal-invasive mechanical thrombectomy using the Penumbra Aspiration System emerged as a successful alternative to surgical embolectomy, enabling prompt treatment and with a short hospital stay for both patients. Our article therefore highlights the use of continuous thrombus aspiration in small diameter vessels and tortuous anatomies, which may represent a contraindication for the use of rotational thrombectomy. In addition, this technique may be applied even in patients with higher bleeding risk since additional lysis is not necessary in patients, where complete thrombus removal can be achieved by this device.


Assuntos
Procedimentos Endovasculares , Trombectomia , Humanos , Trombectomia/instrumentação , Trombectomia/efeitos adversos , Resultado do Tratamento , Masculino , Procedimentos Endovasculares/instrumentação , Procedimentos Endovasculares/efeitos adversos , Idoso , Feminino , Isquemia/diagnóstico , Isquemia/cirurgia , Isquemia/terapia , Pessoa de Meia-Idade , Tromboembolia/etiologia , Tromboembolia/diagnóstico , Doença Aguda
7.
BMJ Case Rep ; 17(9)2024 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-39231563

RESUMO

Iatrogenic acute limb ischaemia (ALI) in neonates is a rare but severe event with potentially deleterious outcomes. In the neonatal intensive care unit, this risk is increased due to the high rate of catheterisation procedures. ALI management includes pharmacological and non-pharmacological interventions, but no commonly accepted clinical guidelines are available. In the present case, a peripheral catheter was erroneously placed in the left brachial artery of a term infant, causing blockage and ischaemia in the limb. The catheter was immediately removed, the affected limb was elevated and warm compresses were applied to the contralateral limb. The patient was treated with fresh frozen plasma, heparin, iloprost and topical nitroglycerin. Three nerve block procedures were also performed. At 6-8 days of age, significant improvement was observed. The patient was discharged at 17 days of age with near-complete resolution, whereas complete resolution was observed at postdischarge follow-up.


Assuntos
Doença Iatrogênica , Isquemia , Humanos , Recém-Nascido , Isquemia/etiologia , Isquemia/terapia , Cateterismo Periférico/efeitos adversos , Artéria Braquial/diagnóstico por imagem , Heparina/administração & dosagem , Heparina/uso terapêutico , Masculino , Nitroglicerina/administração & dosagem , Nitroglicerina/uso terapêutico , Feminino , Vasodilatadores/uso terapêutico , Vasodilatadores/administração & dosagem , Iloprosta/administração & dosagem , Iloprosta/uso terapêutico , Doença Aguda , Bloqueio Nervoso/métodos
8.
J Plast Surg Hand Surg ; 59: 102-107, 2024 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-39246152

RESUMO

PURPOSE: This study aims to investigate whether contrast-enhanced ultrasound (CEUS) could be used to reveal the status of blood supply of the superficial flap of rat model in the early postoperative stage. METHODS: One viable and one ischemic random-pattern flap were prepared on the left and right back of the same rat respectively with a number of 40. CEUS examinations were applied within 12 h and 7 days postoperatively, and the quantitative measurements of microvascular blood volume (BV) of the base and the end of both flaps were expressed using acoustic intensity as a ratio to that of the healthy skin. RESULTS: Within 12 h post operation, there was a smaller BV value of the ischemic ends than that of both the ischemic bases and viable ends (p < 0.001), while no difference was indicated between ischemic bases and viable bases or between viable bases and viable ends. The same result was provided 7 days post operation. CONCLUSION: Microcirculation of superficial tissues such as random-pattern flaps in this rat model can be assessed quantitatively by CEUS. It could sensitively and accurately reveal the objective status of tissue perfusion in the early postoperative stage.


Assuntos
Meios de Contraste , Microcirculação , Retalhos Cirúrgicos , Ultrassonografia , Animais , Retalhos Cirúrgicos/irrigação sanguínea , Microcirculação/fisiologia , Masculino , Ratos Sprague-Dawley , Ratos , Isquemia/diagnóstico por imagem , Período Pós-Operatório , Volume Sanguíneo
9.
Artigo em Russo | MEDLINE | ID: mdl-39248581

RESUMO

Chronic arterial insufficiency of lower limbs (CAILL) is a common cardiovascular disease that affects 200 million subjects worldwide: from 4 to 12% of people aged 55-70 years and 20% - over 70 years. The cause of blood circulation disorder in this disease is usually a complex of pathological changes including abnormality of vessel walls' anatomical structure or integrity, disorder of blood rheological properties and alterations of its thrombotic potential. Thus, the therapy of patients with CAILL aiming at hemostasis and, in particular, platelets' aggregation is one of the most urgent problems of medicine. OBJECTIVE: To study the effectiveness of blue range visible radiation combined with basic therapy to improve hemostasis in patients with CAILL. MATERIAL AND METHODS: The number of male patients with CAILL equal 63 aged 43-57 years was examined. Blood flow parameters on a fixed part of femoral artery outside the occlusion area were registered based on subjective criteria, number of painless steps and ultrasound doppler flowmetry according to the Fontaine-Pokrovsky classification. The second degree of ischemia was diagnosed in 38 patients, the third degree - in 25 patients. All patients received basic pharmacotherapy. Patients were divided into 2 groups by simple randomization method: control group included 18 patients with II degree of ischemia and 12 patients with III degree of ischemia who received basic pharmacotherapy combined with photohemotherapy (PHT). A set of commonly used laboratory methods for examination of blood coagulation system was applied to assess the effectiveness of PHT. The number of apparently healthy people equal 26 was examined to evaluate normal value of hemostasiological parameters. RESULTS: Basic pharmacological treatment had a certain positive effect on studied hemostasis parameters and its thrombotic component. However, they did not differ statistically significantly from similar parameters before treatment on the 14th day after treatment. As a result of comprehensive therapy the changes in hemostasis system had identical and statistically significant in percentage terms changes compared to norm and baseline in patients' subgroups of study group with II and III degrees of ischemia. In addition, most hemostasis parameters in patients with II degree of ischemia were close to those of apparently healthy volunteers. Hemostasis parameters in patients with III degree of ischemia decreased to the levels of patients with II degree of ischemia before treatment. CONCLUSION: The use of basic pharmacological therapy with optical exposure to blood by blue light allows to correct hemostasis and its thrombotic component in patients with CAILL.


Assuntos
Isquemia , Extremidade Inferior , Humanos , Masculino , Pessoa de Meia-Idade , Adulto , Isquemia/terapia , Extremidade Inferior/irrigação sanguínea , Plaquetas , Doença Crônica
10.
Microsurgery ; 44(6): e31237, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39258412

RESUMO

BACKGROUND: In free jejunum transfer, knowing the ischemic tolerance time of the jejunum is crucial. It helps determine the need for reharvesting if an unexpected situation prolongs the ischemic time. The current ischemic tolerance time in humans is unknown. We investigated the relationship between ischemic time and postoperative complications in head and neck cancer patients who underwent free jejunum transfer. METHODS: The study included 76 patients with available medical records out of 103 patients who underwent free jejunum transfer between 2009 and 2023. The association between the surgical procedure, including ischemic time, and patient's background, and flap engraftment, stenosis of the intestinal anastomosis, the swallowing function, and other complications was investigated. RESULTS: The ischemic time for jejunal flaps ranged from 1 h 24 min to 6 h, with a mean of 197 ± 55.5 min. In 72 patients, the jejunum was successfully engrafted, but vascular occlusion occurred in another four patients. In three of these patients, jejunal necrosis occurred, and there was no specific trend in ischemic time. Stenosis of the intestinal anastomosis occurred in 17 cases (22%), with ischemic time (≥3 h) and age (≥75 years) being significant factors for stenosis (ischemic time: 30% vs. 10%, p = 0.048, age: 50% vs. 15%, p < 0.01). No significant correlations were observed with other complications or the swallowing function. CONCLUSION: There was no specific trend between ischemic time and jejunal survival rate, indicating that an ischemic time within 6 h may not have affected engraftment. Although we have recently performed intestinal anastomosis prior to vascular anastomosis, the choice of surgical technique should be adapted to the patient's age and background.


Assuntos
Retalhos de Tecido Biológico , Neoplasias de Cabeça e Pescoço , Isquemia , Jejuno , Complicações Pós-Operatórias , Humanos , Jejuno/transplante , Jejuno/cirurgia , Jejuno/irrigação sanguínea , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Retalhos de Tecido Biológico/irrigação sanguínea , Retalhos de Tecido Biológico/transplante , Retalhos de Tecido Biológico/efeitos adversos , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Adulto , Isquemia/etiologia , Estudos Retrospectivos , Neoplasias de Cabeça e Pescoço/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Procedimentos de Cirurgia Plástica/efeitos adversos , Idoso de 80 Anos ou mais , Sobrevivência de Enxerto , Anastomose Cirúrgica/métodos , Anastomose Cirúrgica/efeitos adversos , Fatores de Tempo
11.
Acta Cir Bras ; 39: e395924, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39258619

RESUMO

PURPOSE: To evaluate exogenous hyaluronic acid (HA) derived from bacterial fermentation through enteral and parenteral routes in ischemic skin flaps induced in rats, using clinical and histological exams; and interleukins (IL) as tissue inflammatory biomarkers. METHODS: Sixty-four male adults Wistar rats with ischemic skin flaps on the dorsum were randomized into four groups, based on the treatment protocol: subcutaneous administration of saline solution (0.9%) (GI); oral administration of distilled water (GII); subcutaneous administration of HA (0.3%) (GIII); and oral administration of HA (1%) (GIV). Flaps of all groups were comparable regarding clinical and macroscopic evaluation, histological examination, pro-inflammatory cytokines (IL-1ß, IL-6, and tumor necrosis factor-α) and anti-inflammatory cytokine IL-10. RESULTS: A lower percentage of necrosis was identified in flaps treated with subcutaneous administration of HA (0.3%). The pro- and anti-inflammatory cytokines, epidermis thickness, blood vessels, and inflammatory cells showed statistically significant inter-group and intra-group differences (p < 0.05). CONCLUSIONS: High molecular HA (1,400 ~ 2,000 kDa) administrated by subcutaneous or oral route exhibited beneficial effects in ischemic skin flaps of rats. However, subcutaneous administration of HA (0.3%) showed better results in terms of the percentage of necrosis and epithelialization.


Assuntos
Ácido Hialurônico , Isquemia , Distribuição Aleatória , Ratos Wistar , Retalhos Cirúrgicos , Animais , Masculino , Ácido Hialurônico/administração & dosagem , Retalhos Cirúrgicos/irrigação sanguínea , Retalhos Cirúrgicos/patologia , Pele/efeitos dos fármacos , Pele/patologia , Método Duplo-Cego , Citocinas/análise , Citocinas/metabolismo , Necrose , Ratos , Administração Oral , Modelos Animais de Doenças , Reprodutibilidade dos Testes
12.
Exp Eye Res ; 247: 110063, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39216638

RESUMO

The main symptom of acute glaucoma is acute ocular hypertension (AOH), which leads to the death of retinal ganglion cells (RGCs) and permanent loss of vision. However, effective treatments for these conditions are lacking. This study aimed to identify major regulators and overall protein changes involved in AOH-induced RGC death. Proteomic patterns of the retinal protein extracts from the AOH and sham groups were analyzed using mass spectrometry (MS), followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Proteomic analysis revealed 92 proteins in the AOH group compared to the control group; 58 proteins were upregulated and 34 were downregulated. Alterations in fatty acid-binding protein 7 (FABP7) and caveolin-1 (Cav-1), which are related to fatty acid metabolism and ocular inflammatory signaling, were detected using western blotting and biochemical assays. Variations in the expression of galectin-1 (Gal-1), S100 calcium-binding protein A6 (S100a6), and visinin-like protein-1 (VILIP) have been associated with neuronal ischemia. Our investigation demonstrates that neuroinflammation and fatty acid metabolism are involved in retinal impairment following AOH, suggesting a possible treatment approach for acute glaucoma.


Assuntos
Western Blotting , Modelos Animais de Doenças , Hipertensão Ocular , Proteômica , Células Ganglionares da Retina , Espectrometria de Massas em Tandem , Animais , Proteômica/métodos , Hipertensão Ocular/metabolismo , Doença Aguda , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/patologia , Pressão Intraocular/fisiologia , Ratos , Masculino , Proteínas do Olho/metabolismo , Hipóxia/metabolismo , Ratos Sprague-Dawley , Isquemia/metabolismo
13.
Sci Rep ; 14(1): 18400, 2024 08 08.
Artigo em Inglês | MEDLINE | ID: mdl-39117675

RESUMO

Estrogens regulate numerous physiological and pathological processes, including wide-ranging effects in wound healing. The effects of estrogens are mediated through multiple estrogen receptors (ERs), including the classical nuclear ERs (ERα and ER ß ), that typically regulate gene expression, and the 7-transmembrane G protein-coupled estrogen receptor (GPER), that predominantly mediates rapid "non-genomic" signaling. Estrogen modulates the expression of various genes involved in epidermal function and regeneration, inflammation, matrix production, and protease inhibition, all critical to wound healing. Our previous work demonstrated improved myocutaneous wound healing in female mice compared to male mice. In the current study, we employed male and female GPER knockout mice to investigate the role of this estrogen receptor in wound revascularization and tissue viability. Using a murine myocutaneous flap model of graded ischemia, we measured real-time flap perfusion via laser speckle perfusion imaging. We conducted histologic and immunohistochemical analyses to assess skin and muscle viability, microvascular density and vessel morphology. Our results demonstrate that GPER is crucial in wound healing, mediating effects that are both dependent and independent of sex. Lack of GPER expression is associated with increased skin necrosis, reduced flap perfusion and altered vessel morphology. These findings contribute to understanding GPER signaling in wound healing and suggest possible therapeutic opportunities by targeting GPER.


Assuntos
Camundongos Knockout , Neovascularização Fisiológica , Receptores de Estrogênio , Receptores Acoplados a Proteínas G , Cicatrização , Animais , Receptores Acoplados a Proteínas G/metabolismo , Receptores Acoplados a Proteínas G/genética , Receptores de Estrogênio/metabolismo , Receptores de Estrogênio/genética , Masculino , Camundongos , Feminino , Pele/metabolismo , Pele/irrigação sanguínea , Isquemia/metabolismo , Retalhos Cirúrgicos
14.
Int J Mol Sci ; 25(15)2024 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-39125579

RESUMO

The retina is one of the highest metabolically active tissues with a high oxygen consumption, so insufficient blood supply leads to visual impairment. The incidence of related conditions is increasing; however, no effective treatment without side effects is available. Furthermore, the pathomechanism of these diseases is not fully understood. Our aim was to develop an optimal ischemic retinopathy mouse model to investigate the retinal damage in a time-dependent manner. Retinal ischemia was induced by bilateral common carotid artery occlusion (BCCAO) for 10, 13, 15 or 20 min, or by right permanent unilateral common carotid artery occlusion (UCCAO). Optical coherence tomography was used to follow the changes in retinal thickness 3, 7, 14, 21 and 28 days after surgery. The number of ganglion cells was evaluated in the central and peripheral regions on whole-mount retina preparations. Expression of glial fibrillary acidic protein (GFAP) was analyzed with immunohistochemistry and Western blot. Retinal degeneration and ganglion cell loss was observed in multiple groups. Our results suggest that the 20 min BCCAO is a good model to investigate the consequences of ischemia and reperfusion in the retina in a time-dependent manner, while the UCCAO causes more severe damage in a short time, so it can be used for testing new drugs.


Assuntos
Modelos Animais de Doenças , Proteína Glial Fibrilar Ácida , Hipóxia , Isquemia , Retina , Tomografia de Coerência Óptica , Animais , Camundongos , Isquemia/metabolismo , Isquemia/patologia , Proteína Glial Fibrilar Ácida/metabolismo , Retina/metabolismo , Retina/patologia , Hipóxia/metabolismo , Doenças Retinianas/metabolismo , Doenças Retinianas/patologia , Doenças Retinianas/etiologia , Masculino , Células Ganglionares da Retina/patologia , Células Ganglionares da Retina/metabolismo , Camundongos Endogâmicos C57BL , Fatores de Tempo
15.
J Nanobiotechnology ; 22(1): 470, 2024 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-39118029

RESUMO

Thrombotic cardiovascular diseases are a prevalent factor contributing to both physical impairment and mortality. Thrombolysis and ischemic mitigation have emerged as leading contemporary therapeutic approaches for addressing the consequences of ischemic injury and reperfusion damage. Herein, an innovative cellular-cloaked spermatozoon-driven microcellular submarine (SPCS), comprised of multimodal motifs, was designed to integrate nano-assembly thrombolytics with an immunomodulatory ability derived from innate magnetic hyperthermia. Rheotaxis-based navigation was utilized to home to and cross the clot barrier, and finally accumulate in ischemic vascular organs, where the thrombolytic motif was "switched-on" by the action of thrombus magnetic red blood cell-driven magnetic hyperthermia. In a murine model, the SPCS system combining innate magnetic hyperthermia demonstrated the capacity to augment delivery efficacy, produce nanotherapeutic outcomes, exhibit potent thrombolytic activity, and ameliorate ischemic tissue damage. These findings underscore the multifaceted potential of our designed approach, offering both thrombolytic and ischemia-mitigating effects. Given its extended therapeutic effects and thrombus-targeting capability, this biocompatible SPCS system holds promise as an innovative therapeutic agent for enhancing efficacy and preventing risks after managing thrombosis.


Assuntos
Isquemia , Espermatozoides , Trombose , Animais , Masculino , Camundongos , Isquemia/terapia , Espermatozoides/efeitos dos fármacos , Trombose/tratamento farmacológico , Terapia Trombolítica/métodos , Hipertermia Induzida/métodos , Fibrinolíticos/farmacologia , Fibrinolíticos/uso terapêutico , Fibrinolíticos/química , Humanos , Camundongos Endogâmicos C57BL
16.
Cells ; 13(15)2024 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-39120274

RESUMO

MicroRNAs (miRs) regulate physiological and pathological processes, including ischemia-induced angiogenesis and neovascularization. They can be transferred between cells by extracellular vesicles (EVs). However, the specific miRs that are packaged in EVs released from skeletal muscles, and how this process is modulated by ischemia, remain to be determined. We used a mouse model of hindlimb ischemia and next generation sequencing (NGS) to perform a complete profiling of miR expression and determine the effect of ischemia in skeletal muscles, and in EVs of different sizes (microvesicles (MVs) and exosomes) released from these muscles. Ischemia significantly modulated miR expression in whole muscles and EVs, increasing the levels of several miRs that can have pro-angiogenic effects (angiomiRs). We found that specific angiomiRs are selectively enriched in MVs and/or exosomes in response to ischemia. In silico approaches indicate that these miRs modulate pathways that play key roles in angiogenesis and neovascularization, including HIF1/VEGF signaling, regulation of actin cytoskeleton and focal adhesion, NOTCH, PI3K/AKT, RAS/MAPK, JAK/STAT, TGFb/SMAD signaling and the NO/cGMP/PKG pathway. Thus, we show for the first time that angiomiRs are selectively enriched in MVs and exosomes released from ischemic muscles. These angiomiRs could be targeted in order to improve the angiogenic function of EVs for potential novel therapeutic applications in patients with severe ischemic vascular diseases.


Assuntos
Vesículas Extracelulares , Isquemia , MicroRNAs , Músculo Esquelético , Neovascularização Fisiológica , Animais , Músculo Esquelético/metabolismo , Músculo Esquelético/irrigação sanguínea , Músculo Esquelético/patologia , Vesículas Extracelulares/metabolismo , MicroRNAs/metabolismo , MicroRNAs/genética , Isquemia/metabolismo , Isquemia/patologia , Camundongos , Membro Posterior/irrigação sanguínea , Membro Posterior/patologia , Camundongos Endogâmicos C57BL , Transdução de Sinais , Masculino , Exossomos/metabolismo , Neovascularização Patológica/metabolismo , Angiogênese
17.
Dtsch Med Wochenschr ; 149(17): 1002-1008, 2024 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-39146746

RESUMO

The rate of vascular recanalizations in CLTI is increasing worldwide. Safety and efficacy of surgical versus endovascular treatment in CLTI patients was investigated in 2 prospective randomized trials with contrasting results. The BEST-CLI trial randomized 1830 patients with CLTI, the Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL-2) trial included 345 patients with CLTI. Best-CLI evaluated outcome events as the primary endpoint, which includes major reinterventions in addition to major amputations and death. Only half of the CLTI patients received a crural intervention or surgery. There were no differences in major amputations or death. After a median follow-up (FU) of 2,7 years, the surgery group showed significantly better results compared to the endovascular group, due to fewer re-interventions. BASIL-2 used amputation-free survival as the primary outcome and only included patients with lower leg lesions. After a median FU of 40 months, endovascular therapy was found to be superior. The extremely high mortality rate was remarkable in both studies. The BEST-CLI study represents CLTI patients only to a limited degree, whereas the BASIL-2 study presents the treatment of CLTI patients with below-the-knee-lesions quite well. Both studies confirm that patients with CLTI should be treated in specialized centers that offer both crural surgery and endovascular therapy. Cardiovascular risk factor management must play a more important role in reducing the high mortality associated with CLTI.


Assuntos
Amputação Cirúrgica , Humanos , Isquemia Crônica Crítica de Membro/cirurgia , Isquemia Crônica Crítica de Membro/terapia , Isquemia/terapia , Procedimentos Endovasculares/métodos , Masculino , Resultado do Tratamento , Idoso , Feminino , Pessoa de Meia-Idade
18.
BMJ Open Ophthalmol ; 9(1)2024 Aug 13.
Artigo em Inglês | MEDLINE | ID: mdl-39142698

RESUMO

AIMS: To explore the sensitive components of full-field electroretinography (ERG) as indicators of retina function at the onset of acute ischaemic central retinal vein occlusion (CRVO). METHODS: 11 patients (11 eyes) with ischaemic CRVO and 32 patients (32 eyes) with non-ischaemic CRVO who presented with first-episode unilateral CRVO within 1 month of symptom onset and with no previous intervention were examined by the International Society for Clinical Electrophysiology of Vision standard ERG. RESULTS: A significant amplitude decline and peak time delay in light-adapted (LA) 3 ERG and LA 30 Hz flicker ERG (p<0.05 for all) was found in the ischaemic CRVO eyes, compared with the non-ischaemic CRVO eyes. The b/a amplitude ratio of dark-adapted (DA) 3 ERG, DA 10 ERG and LA 3 ERG was significantly different between the ischaemic and non-ischaemic groups (p<0.05 for all). Regarding oscillatory potentials (OPs), the amplitudes of OP1, OP2 and OP3 as well as the sum of DA 3 OP1-4 amplitudes (∑OPs) showed significant changes (p<0.01 for all) between two groups. No peak time delay of OPs was found between the ischaemic and non-ischaemic CRVO eyes. CONCLUSION: The amplitude of DA 0.01 ERG, components of LA 3 ERG and LA 30 Hz flicker ERG, and the b/a amplitude ratio could be among the most sensitive indicators in patients with acute ischaemic CRVO. The amplitudes of OP1, OP2, OP3 and ∑OPs in the CRVO eyes were reduced to 40% of the control values, showing that this quantitative method is reliable for detecting ischaemic retinal diseases, even in early stage.


Assuntos
Eletrorretinografia , Isquemia , Retina , Oclusão da Veia Retiniana , Humanos , Oclusão da Veia Retiniana/fisiopatologia , Oclusão da Veia Retiniana/diagnóstico , Eletrorretinografia/métodos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Doença Aguda , Isquemia/fisiopatologia , Isquemia/diagnóstico , Retina/fisiopatologia , Retina/diagnóstico por imagem , Acuidade Visual/fisiologia , Adaptação à Escuridão/fisiologia , Adulto
19.
Adv Surg ; 58(1): 121-133, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39089772

RESUMO

Chronic limb-threatening ischemia is defined as ischemic rest pain or tissue loss (eg, ulceration/gangrene) that has been present for greater than 2 weeks. Workup includes a careful history, physical examination focused on evaluation of pulses and wounds, lower extremity noninvasive vascular studies (eg, ankle-brachial indices, toe pressures), saphenous vein mapping, and imaging of the lower extremity arterial anatomy (eg, computed tomography, magnetic resonance, or subtraction angiography) if a revascularization intervention is planned.


Assuntos
Procedimentos Endovasculares , Isquemia , Humanos , Procedimentos Endovasculares/métodos , Isquemia/cirurgia , Isquemia/etiologia , Doença Crônica , Procedimentos Cirúrgicos Vasculares/métodos , Extremidade Inferior/irrigação sanguínea , Isquemia Crônica Crítica de Membro/cirurgia , Salvamento de Membro/métodos
20.
Adv Surg ; 58(1): 235-247, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39089780

RESUMO

Critical limb ischemia is an important clinical entity due to its association with increased morbidity and mortality. The mortality and amputation-free survival remains poor especially in those where revascularization is not an option. Recently, the role of cellular therapy has emerged as a promising therapeutic measure that may aid in wound healing and revascularization and improve functional outcomes.


Assuntos
Isquemia , Cicatrização , Humanos , Cicatrização/fisiologia , Isquemia/terapia , Transplante de Células-Tronco/métodos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA